Glycaemia monitoring gets central role in Irish type 2 diabetes guidelines
This article was originally published in Clinica
Blood glucose monitoring is a central element of Irish guidelines on the identification and management of type 2 diabetes. Around a quarter of a million people – 5% of the population – is believed to have the condition, but "the true prevalence is underestimated", acknowledges the health ministry, which is reporting "dramatic increases" in case numbers.
You may also be interested in...
Divesting the heart valve division will allow LivaNova to focus more resources on its neuromodulation, cardiopulmonary and circulatory support businesses.
The US FDA tells manufacturers in two recent warning letters to get to the root cause of contamination problems and take a more proactive approach to cleaning and equipment maintenance.
Device Week, 4 December 2020 – MedWatch Question About Third-Party Servicers Slides Under Industry's Radar
On this week’s podcast: A change made by the US FDA to its MedWatch program that asks adverse event reporters whether a third party serviced a malfunctioning medical device went unnoticed by many in industry for nearly a year. We explain why, and tell how the servicer question will be helpful for manufacturers and the agency.